Toggle light / dark theme

Morals versus money: How we make social decisions

The researchers found that people have a moral preference for supporting good causes and not wanting to support harmful or bad causes. However, depending on the strength of the monetary incentive, people will at one point switch to selfish behavior. When the authors reduced the excitability of the rTPJ using electromagnetic stimulation, the participants’ moral behavior remained more stable.

“If we don’t let the brain deliberate on conflicting moral and monetary values, people are more likely to stick to their moral convictions and aren’t swayed, even by high financial incentives,” explains Christian Ruff. According to the neuroeconomist, this is a remarkable finding, since: “In principle, it’s also conceivable that people are intuitively guided by financial interests and only take the altruistic path as a result of their deliberations.”


Our actions are guided by moral values. However, monetary incentives can get in the way of our good intentions. Neuroeconomists at the University of Zurich have now investigated in which area of the brain conflicts between moral and material motives are resolved. Their findings reveal that our actions are more social when these deliberations are inhibited.

When donating money to a charity or doing volunteer work, we put someone else’s needs before our own and forgo our own material interests in favor of moral values. Studies have described this behavior as reflecting either a personal predisposition for altruism, an instrument for personal reputation management, or a mental trade-off of the pros and cons associated with different actions.

Impact of electromagnetic stimulation on donating behavior

A research team led by UZH professor Christian Ruff from the Zurich Center for Neuroeconomics has now investigated the neurobiological origins of unselfish behavior. The researchers focused on the right Temporal Parietal Junction (rTPJ) — an area of the brain that is believed to play a crucial role in social decision-making processes. To understand the exact function of the rTPJ, they engineered an experimental set-up in which participants had to decide whether and how much they wanted to donate to various organizations. Through electromagnetic stimulation of the rTPJ, the researchers were then able to determine which of the three types of considerations — predisposed altruism, reputation management, or trading off moral and material values — are processed in this area of the brain.

We are happy to announce Dr. Ruth Itzhaki as a speaker for the 2019 Undoing Aging Conference

“Ruth is a shining example of one of the qualities I most admire in a scientist: dogged perseverance in pursuit of one’s thesis, in spite of near-universal rejection of it by the mainstream community, until one finally wins them round.

It’s only an admirable quality if you’re likely to be right, of course, so you’d better be a really good scientist in other ways too — and she sure is. Ruth spoke at a couple of my Cambridge conferences and I was always dismayed that such solid data and logic concerning the involvement of herpes simplex virus in Alzheimer’s disease was so widely ignored or dismissed for what seemed to be totally flimsy reasons. That’s not happening any more!”, says Aubrey de Grey.

https://www.undoing-aging.org/news/dr-ruth-itzhaki-to-speak-…aging-2019

Read more

A single transistor process that can create connections

A single transistor process that can create connections, and encode short and long term memories. The transistor is based on organic versus inorganic technology. The project relies on a form of transistor that uses ion injection from an electrolyte solution, which changes the storage and connectivity of the transistor.

The end result, a simple learning circuit to replicate neuronal action.

News Article: https://www.sciencedaily.com/releases/2019/02/190205102537.htm

Read more

Autism spectrum disorders may stem from multiple factors

Diagnosed cases of autism spectrum disorder (ASD) in California rose by 600 percent from 1990 to 2003. Irva Hertz-Picciotto, Ph.D., director of the Environmental Health Sciences Core Center at the University of California-Davis, published this statistic in the journal Epidemiology a decade ago.

The esteemed epidemiologist told the audience during the Jan. 8 NIEHS Distinguished Lecture that she and her colleagues have only been able to explain a third of the increase.

“No single factor accounts for all autism cases, nor is there one event or exposure that can be responsible for the rapid increase in diagnoses,” said Hertz-Picciotto. “Each child’s path to altered brain development may be different.” Her talk was hosted by NIEHS and National Toxicology Program (NTP) Director Linda Birnbaum, Ph.D.

Read more

Finding Differences in Brain Connectivity May Aid in Autism Diagnosis

New research looks at distinctive differences in brain connectivity that may underlie autism spectrum disorders (ASD) — and possibly provide much-needed biomarkers to aid in identifying the disorder.

Diagnosis for ASD is still behaviorally based. But getting a diagnosis can take longer due to several factors, including lack of resources and trained clinicians. This delays autism diagnosis, on average, until age 5 or 6.

“Within ASD, two important research questions are: How can we minimize the delay in diagnosis, and what kind of intervention can we give the child?” said Rajesh Kana, Ph.D., associate professor of psychology in the UAB College of Arts and Sciences.

Read more

No Chemo, No Cancer: Trial Eradicates All Signs of Breast Tumors in Only 11 Days

Despite unbelievable advances in medical science in recent decades, breast cancer kills. Approximately 1 in 8 American women will develop breast cancer cells during the course of their lifetime.

Finding a cure is imperative, and as such, fervent research continues. At the European Breast Cancer Conference in Amsterdam, scientists presented a pair of drugs with an astounding claim: this treatment can eradicate some types of breast cancer in only 11 days, eliminating the need for chemotherapy.

Chemotherapy, whilst an amazing feat of medical-scientific engineering, is known for its uncomfortable and sometimes debilitating side effects. Women undergoing chemotherapy for breast cancer treatment may lose their hair, suffer extreme fatigue, and even loss of cognitive function.

Read more